Veracyte
Highly Engaged Employees
Highly Engaged EmployeesHealthcare Services · California, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
6000 Shoreline Ct Ste 300, South San Fra...Phone Number
(650) 243-6300Website
www.veracyte.comRevenue
$561.9 MillionStock Symbol
VCYTIndustry
ZI Rank: 12
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
14
15
17
12
12
12
About Veracyte
Founded in 2006, Veracyte is emerging in the field of molecular cytology by developing molecular tests designed to improve the diagnostic accuracy of cytology samples and also helping to increase the utility of minimally invasive procedures as an alternative to surgical biopsy. The company is headquartered in San Francisco, California.Explore more
Veracyte Org Chart
Get the full picture
Sign in to uncover key details.
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Veracyte your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Veracyte, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Veracyte recently announced quarterly report
Product Launch: Get notified when Veracyte launches new products
Funding: Get notified immidiatlly once Veracyte has new funding data
Congratulate Masked Content for being promoted to Masked Content at Veracyte
Check out if Veracyte is spiking on competitors!
Website visits: Recent activity has been detected on your website
Click to see if Veracyte had a recent Job posting/layoffs
Check if Veracyte has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Veracyte as Masked Content
Find 3 more new buyers
Compare Similar Companies to Veracyte
Compare insights from companies similar to Veracyte, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Veracyte is experiencing low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Veracyte is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Veracyte.
Veracyte financials insights
Gather financial insights about Veracyte, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2010
Series B
$28M
2013
Series C
$28M
Stock Offering
$58M
2015
Share Placement
$40M
2016
Debt
$45M
Stock Offering
$31.9M
2018
Stock Offering
$55.1M
2019
Stock Offering
$137.9M
2020
Stock Offering
$194M
Veracyte Tech Stack
A closer look at the technologies used by Veracyte
See more technologies
Most Recent Scoops
Person-Based
Spending/Investment, Product Launch
Person-Based
Medical Research
Project
Veracyte has reported that OPTIMA trial data, presented at ASCO, demonstrated that two out of three women receiving chemotherapy do not need it and that omitting chemotherapy does not impact outcomes, marking the first trial to examine patients with three or more nodes in the premenopausal population.
Clinical Operations
Earnings
Veracyte has reported Decipher revenue growth of 20% for Q2, while volume growth came in at 17%, the first time below 20% in approximately 12 to 13 quarters, with the volume shortfall of approximately 700 tests concentrated in the low-risk setting.
Earnings, Finance
Project
Medical Research
Veracyte News & Media
Veracyte Announces Second Quarter 2026 Financial Results
Grew total revenue to $150.3 million and testing revenue to $145.7 million, representing increases of 15% and 19% year-over-year, respectively Conference call and webcast today at 4:30 p.m. ETVeracyte to Participate in Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif., July 28, 2026 (GLOBE NEWSWIRE) -- Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, announced today that it will be participating in the following investor conferences:A Veracyte Insider Sold 24,000 Company Shares for $1.1 Million. Here's a Deeper Look at the Transaction.
This genomic diagnostics company saw a notable insider sale, as shares have surged over 70% in the past year.What to Know About This $197,000 Veracyte Insider Sale After a 120% Stock Rally
This genomics diagnostics specialist, up over 120% in a year, reported a notable insider sale amid ongoing scheduled dispositions.
Read more news
Top Healthcare Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Veracyte
Sign Up For FreeTo access detailed company insights
Founded in 2006, Veracyte is emerging in the field of molecular cytology by developing molecular tests designed to improve the diagnostic accuracy of cytology samples and also helping to increase the utility of minimally invasive procedures as an alternative to surgical biopsy. The company is headquartered in San Francisco, California.... Read More
